Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ARMS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01519661
What this trial is testing

Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Who this might be right for
Pulmonary InfectionsPseudomonas Aeruginosa in Cystic Fibrosis
Novartis Pharmaceuticals 157
Large-scale testing (Phase 3)Study completedNCT00467870
What this trial is testing

Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men

Who this might be right for
HypogonadismPrimary HypogonadismSecondary Hypogonadism
Endo USA Inc., a Keenova Therapeutics Company 531
Not applicableLooking for participantsNCT06689670
What this trial is testing

Needle-based Percutaneous Ablation of Liver Tumors.

Who this might be right for
Liver TumorsHCC - Hepatocellular CarcinomaMetastatic Liver Tumor
inTumo Therapeutics, Inc. 31
Testing effectiveness (Phase 2)Ended earlyNCT02452970
What this trial is testing

RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy

Who this might be right for
Cholangiocarcinoma
EpicentRx, Inc. 4
Early research (Phase 1)Not Yet RecruitingNCT06712173
What this trial is testing

Linperlisib Combined With EZH2 Inhibitor in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Peripheral T Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 33
Testing effectiveness (Phase 2)UnknownNCT06149169
What this trial is testing

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinDiffuse Large B Cell Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd. 10
Not applicableStudy completedNCT02667405
What this trial is testing

The Short Term Effect of Hot Packs and Whirlpool for Increasing Total Active Motion at the Wrist

Who this might be right for
Distal Radius Fracture
Western University, Canada 61
Early research (Phase 1)Study completedNCT02583594
What this trial is testing

Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
Genzyme, a Sanofi Company 24
Not applicableStudy completedNCT04036422
What this trial is testing

Effects of a Computerised Exercise System on Functionality of the Arm,Cognition and Quality of Life in Stroke Patients

Who this might be right for
StrokeNeuronal PlasticityHemiplegia
Baskent University 30
Testing effectiveness (Phase 2)Looking for participantsNCT04712851
What this trial is testing

Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical Squamous Cell Carcinoma In SituCervical Squamous Intraepithelial Neoplasia 2
Jonsson Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06508229
What this trial is testing

Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Harbin Medical University 65
Early research (Phase 1)Study completedNCT04577703
What this trial is testing

First-In-Human Phase I Trial of Ningetinib ( CT053PTSA ) in the Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Sunshine Lake Pharma Co., Ltd. 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05346354
What this trial is testing

Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 12
Testing effectiveness (Phase 2)UnknownNCT05519202
What this trial is testing

Exploratory Clinical Study of Penpulimab Combined With SOX in the Perioperative Treatment of Gastric Cancer

Who this might be right for
Gastric Cancer
The Central Hospital of Lishui City 47
Testing effectiveness (Phase 2)UnknownNCT04812002
What this trial is testing

Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy

Who this might be right for
Gestational Trophoblastic Neoplasia
Women's Hospital School Of Medicine Zhejiang University 20
Not applicableStudy completedNCT05570877
What this trial is testing

ChitoCare Medical Wound Healing Gel PMCF Study on Healing of Chronic Wounds

Who this might be right for
Diabetic Foot UlcerVenous Leg UlcerPressure Ulcer
Primex ehf 92
Not applicableLooking for participantsNCT06543277
What this trial is testing

Safety and Feasibility of Paired Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) With Upper Limb Rehabilitation in Incomplete Spinal Cord Injury

Who this might be right for
Chronic Incomplete Cervical Spinal Cord Injury (SCI)
The University of Texas Health Science Center, Houston 12
Not applicableStudy completedNCT06784102
What this trial is testing

Clinical Evaluation of Pain and Debonding Forces with Damon Clear Debonding Plier Utilizing a Third Wedging Arm

Who this might be right for
Pain Intensity Assessment
University of Baghdad 40
Early research (Phase 1)Not Yet RecruitingNCT07660939
What this trial is testing

GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders

Who this might be right for
Plasma Cell DisordersMultiple Myeloma (MM)
Peking University First Hospital 50
Large-scale testing (Phase 3)Ended earlyNCT02641639
What this trial is testing

FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer

Who this might be right for
Platinum Resistant Ovarian Cancer
Mateon Therapeutics 70
Next Page